Biopharmaceutical co. Tvardi Therapeutics raises $74M to advance clinical pipeline, grow team
The Houston firm’s scientific advisory has ties to scientists at the M.D. Anderson Cancer Center.
HoustonNewMedia.org
Building "Bridges" Across the Bayou City!
